Mineralys Therapeutics, Inc. Gains 86.43%
Tue, Sep 02, 2025 at 07:30 PM
Mineralys Therapeutics, Inc. (MLYS:NASDAQ) rocketted at $28.86, a gain of 86.4%. On Tue, Sep 02, 2025, MLYS:NASDAQ hit a New 2-Week High of $28.86. The stock got featured on our News Catalysts scanner on Tue, Sep 02, 2025 at 06:30 PM in the 'PUBLIC OFFERING' category. From Tue, Aug 19, 2025, the stock recorded 77.78% Up Days and 60.00% Green Days
About Mineralys Therapeutics, Inc. (MLYS:NASDAQ)
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone.
Top 10 Gainers:
- Movella Holdings Inc. (MVLA:NASDAQ), 4445.45%
- Hempacco Co., Inc. (HPCO:NASDAQ), 350%
- HWH International Inc. (HWH:NASDAQ), 225.52%
- Carisma Therapeutics, Inc. (CARM:NASDAQ), 104.65%
- Mineralys Therapeutics, Inc. (MLYS:NASDAQ), 86.43%
- Sound Group Inc. (SOGP:NASDAQ), 82.4%
- Universal Safety Products, Inc (UUU:NYSEMKT), 75.15%
- Robot Consulting Co. Ltd. (LAWR:NASDAQ), 70.41%
- Luda Technology Group Limited (LUD:NYSEMKT), 62.6%
- SHF Holdings, Inc. (SHFS:NASDAQ), 51.77%